Global supply chains are under pressure—but yours doesn’t have to be. At LifeScience Logistics, we help life sciences companies stay ahead of tariff-related volatility. With purpose-built infrastructure and strategic flexibility, we offer rapid access to: 🟢 Cold chain logistics 🟢 Foreign Trade Zone (FTZ) storage 🟢 Validated warehouse space 🟢 Turnkey fulfillment operations And yes—we have space available now. Learn more about our immediate capacity and capabilities: https://lnkd.in/exANZVGx
Clinical Trial Ops Management | First-in-Human to Late-Phase
1wSmart framing and timing. Chris, would you care to educate me at all about the implications of nearshoring/reshoring/domestic manufacturing increases of life science products for the trucking and logistics/transportation industry? Specifically: In your opinion, is this likely to impact revenues negatively due to, e.g. decreased transportation originating from ports, is it likely to be overall neutral due to reciprocal increases of traffic from other locations (e.g. domestic warehouses or manufacturing facilities), or is it likely to be beneficial, due perhaps to avoiding port congestion and long lines, an issue even lay people like me have heard about, possibly coupled with shorter load delivery distances and other increased efficiencies? I ask because I am quite ignorant to the finer details of your industry, and had never considered this question until I saw this (re)post. So thank you generally, and also I'm grateful for any insight an expert like yourself can provide to help me learn something new.